A lung adenocarcinoma patient with co-mutations of MET and EGFR exon20 insertion responded to crizotinib

Overview of attention for article published in BMC Medical Genomics, June 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (67th percentile)

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 940 followers.

A lung adenocarcinoma patient with co-mutations of MET and EGFR exon20 insertion responded to crizotinib https://t.co/MRBLoIKkzC

New article: A lung adenocarcinoma patient with co-mutations of MET and EGFR exon20 insertion responded to crizotinib https://t.co/z1E9MN0fa7 #lungcancer #oncology https://t.co/oxt5xQZVqr

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.